Sarah Smith joins as head of Simmons’ UK competition and antitrust team following predecessor’s exit for Kirkland last year | 1yr
Life Sciences - Page 4
US firm's fourth European office to offer privacy and data security services to tech and life sciences clients | 1yr
Joiners arrive from Hausfeld, Pinsent Masons and Gowling WLG | 1yr
Patent litigator Alexander Ritter marks latest in string of European hires by the US firm | 1yr
This second edition delivers a comparative analysis of cryptoasset regulation in a rapidly evolving global legal landscape. | 1mo
Jones Day, Linklaters and Arnold & Porter also called in for the largest healthcare buyout of 2024 | 1yr
Results show EU Commission’s security initiative is having success in tackling counterfeits | 1yr
Firm says hire underscores commitment to strengthening UK IP practice | 1yr
Merged firm to house 230 professionals and operate under Venner Shipley name | 1yr
Laurence Lieberman led his former firm’s life sciences commercial disputes group | 1yr
Firm chair Alden Millard points to bolstering global M&A bench as a ‘priority’ | 1yr
Thomas Kendra brings emerging markets expertise to his new firm notably through his Africa work | 1yr
Jenny Davies joins as a partner in Cooley’s London life sciences partnering and licensing practice | 1yr
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 1yr
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1yr
Arrival of Tim Powell continues US firm’s European IP push | 1yr
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1yr
Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 1yr
Tie-up to create firm with revenues of $810m and more than 1,000 lawyers | 1yr
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 1yr
Troutman Pepper Locke to have 1,600 lawyers across 33 US and two European offices | 1yr